Therachon , a developer of innovative therapies for achondroplasia, announced today that it closed a $35 million Series A round. The funds will be used to advance Therachon's lead program, a soluble form of human fibroblast growth factor receptor 3, ... Citybizlist, 3 days ago
NEA Joins $35M Series A for Therachon - Citybizlist, 3 days ago
Read more on: National Front , Marine Le Pen , France 10:23 27/08/2015 After the revisionist statement by Jean Marie Le Pen on the genocide of Jews during World War II, his daughter Marine Le Pen, who is the president of the National ...Valdai Club, 1 month ago
To be able to function, cell mitochondria import "fuel" using a carrier, the Mitochondrial Pyruvate Carrier (MPC). In order to determine whether the MPC is still functional in malignant cells, the team of Professor Jean-Claude Martinou, at the ...Medical Design Technology, 1 month ago
on your WebpageAdd Widget >Get your members hooked!